almal > RightWingAd
almal > LeftWingAd

Pharmaceutical companies reported EGP 5.2bn sales in May

Wednesday 27 June 2018 01:30 PM


By Ahmed Sabry
Pharmaceutical companies operating in the Egyptian market achieved 5.2 billion pounds direct sales (excluding tenders) during the month of May, a growth rate of 27.4% compared to the same period last year.

According to a report by the IMS, the international drug information firm, the Swiss company Novartis maintained the top position in the list of best-selling companies for the third year in a row with a 7.8% market share.

In addition, GlaskoSmithline ranked second behind Novartis, with a 5.6 % market share, followed by Egypt's FARCO Group, which took third place form French Sanofi, with a 4.7%  market share